Anti-SIGLEC5 Immunohistochemistry Kit (CAT#: VS-0525-XY6583)
The SIGLEC5 IHC kit provides high-quality, specific staining. Complete with all necessary reagents, it is compatible with both paraffin and frozen tissue sections, offering flexibility and reproducibility for immune-related studies.
Specific Inquiry
Normal Tissue
RNA Expression
Figure 1 IHC staining of human bone marrow
(Immunohistochemical staining of human bone marrow shows strong cytoplasmic positivity in subsets of bone marrow poietic cells.)
* Image credit: Human Protein Atlas v21.proteinatlas.org/images/9085/ihc_selected.jpg
(Immunohistochemical staining of human bone marrow shows strong cytoplasmic positivity in subsets of bone marrow poietic cells.)
* Image credit: Human Protein Atlas v21.proteinatlas.org/images/9085/ihc_selected.jpg
Figure 2 Liver
(Hepatocytes Staining: Low Intensity: Moderate Quantity: <25% Location: Cytoplasmic/ membranous)
* Image credit: Human Protein Atlas v21.proteinatlas.org/images/24900/58939_A_8_4.jpg
(Hepatocytes Staining: Low Intensity: Moderate Quantity: <25% Location: Cytoplasmic/ membranous)
* Image credit: Human Protein Atlas v21.proteinatlas.org/images/24900/58939_A_8_4.jpg
Figure 3 Bone marrow
(Hematopoietic cells Staining: High Intensity: Strong Quantity: 75%-25% Location: Cytoplasmic/ membranous)
* Image credit: Human Protein Atlas v21.proteinatlas.org/images/24900/58939_B_4_4.jpg
(Hematopoietic cells Staining: High Intensity: Strong Quantity: 75%-25% Location: Cytoplasmic/ membranous)
* Image credit: Human Protein Atlas v21.proteinatlas.org/images/24900/58939_B_4_4.jpg
Figure 4 Lymph node
(Non-germinal center cells Staining: Medium Intensity: Strong Quantity: <25% Location: Cytoplasmic/ membranous)
* Image credit: Human Protein Atlas v21.proteinatlas.org/images/24900/58939_A_8_8.jpg
(Non-germinal center cells Staining: Medium Intensity: Strong Quantity: <25% Location: Cytoplasmic/ membranous)
* Image credit: Human Protein Atlas v21.proteinatlas.org/images/24900/58939_A_8_8.jpg
Figure 5 RNA cell line category: Group enriched (HMC-1, U-937)
(Cell lines ordered by descending RNA expression order.)
* Image credit: Human Protein Atlas v21.proteinatlas.org/ENSG00000105501-SIGLEC5
(Cell lines ordered by descending RNA expression order.)
* Image credit: Human Protein Atlas v21.proteinatlas.org/ENSG00000105501-SIGLEC5
Specifications
- Application
- IHC
- Size
- 50 Tests
- Species Reactivity
- Human
- Target
- SIGLEC5
- Primary Antibody
- Mouse Anti-SIGLEC5 Antibody
- Secondary Antibody
- Goat anti-Mouse Antibody, HRP
- Sample Type
- FFPE tissue; Frozen section tissue
- Kit Storage
- All reagents should be kept at 2-8°C. The kit remains stable for up to 6 months after arrival.
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
See other products for "SIGLEC5"
Select a product category from the dropdown menu below to view related products.
Please select product type
IgG Antibody Products
Neutralizing Antibody Products
IHC Kit and Antibody Products: Precision Tools for Immunohistochemistry
| CAT | Product Name | Application | Type |
|---|---|---|---|
| MOB-2886z | Mouse Anti-SIGLEC5 Recombinant Antibody (clone 14F8) | ELISA, FC, ICC, IHC, IP | Mouse IgG1 |
| MOB-1377CT | Recombinant Mouse anti-Human SIGLEC5 Monoclonal antibody (2B6) | ELISA, FC, ICC/IF, IHC-Fr, IP, Neut, WB |
Customer Reviews and Q&As
There are currently no Customer reviews or questions for VS-0525-XY6583. Click the button above to contact us or submit your feedback about this product.
Popular products with customers
Application: IP, IF, FuncS, FC, Neut, ELISA, ICC
Application: ELISA, IHC
Application: IF, IP, Neut, FuncS, ELISA, FC, ICC
Application: IP, IF, FuncS, FC, Neut, ELISA, IHC
Application: ELISA, IHC, FC, WB, IF, IA
Application: WB, ELISA, FC, IHC, IF, IP
Application: FC, IHC, Cyt, FuncS
Application: FC
-2.png)
Application: WB, ELISA, FuncS
For Research Use Only. Not For Clinical Use.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
